Jupiter, FL, United States of America

Alex Nanna

This inventor holds 1 USPTO granted patent. Top assignee: Scripps Research Institute. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alex Nanna. Retrieved from https://idiyas.com/inventor/alex-nanna

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Alex Nanna: Innovator in Immunoconjugate Technology

Introduction

Alex Nanna is a prominent inventor based in Jupiter, FL (US). He has made significant contributions to the field of immunoconjugates, particularly in the development of dual variable domain immunoconjugates. His work focuses on innovative solutions for the prevention and treatment of cancer and other diseases.

Latest Patents

Alex Nanna holds a patent for "Dual variable domain immunoconjugates and uses thereof." This patent describes dual variable domain (DVD) immunoconjugates that include a DVD immunoglobulin molecule with a first and second variable domain. A cargo moiety, such as a drug moiety, is covalently conjugated to the second variable domain via a linker. The patent outlines methods for making and using these immunoconjugates in medical applications.

Career Highlights

Alex Nanna is affiliated with The Scripps Research Institute, where he continues to advance research in immunoconjugate technology. His work has the potential to impact cancer treatment significantly.

Collaborations

Some of his notable coworkers include Christoph Rader and William R. Roush, who contribute to the collaborative research environment at The Scripps Research Institute.

Conclusion

Alex Nanna's innovative work in dual variable domain immunoconjugates exemplifies the potential of scientific research to address critical health challenges. His contributions are paving the way for new therapeutic strategies in the fight against cancer and other diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…